Howard Frazier.

Mark S. Slaughter, M.D., Joseph G. Rogers, M.D., Carmelo A. Milano, M.D., Stuart D. Russell, M.D., John V. Conte, M.D., David Feldman, M.D., Ph.D., Benjamin Sun, M.D., Antone J. Tatooles, M.D., Reynolds M. Delgado, III, M.D., James W. Long, M.D., Ph.D., Thomas C. Wozniak, M.D., Waqas Ghumman, M.D., David J. Farrar, Ph.D., and O. Howard Frazier, M.D. For the HeartMate II Investigators: Advanced Heart Failure Treated with Continuous-Stream Remaining Ventricular Assist Device.But for enough time being, Wessell said that he and his co-workers initially thought that overweight and obese patients would want more operative time and larger surgical publicity, both of which would business lead to a greater dependence on blood transfusions. To explore that theory, the group analyzed data concerning nearly 900 hip surgery patients and a lot more than 1,500 knee surgery sufferers who had joint replacement procedures at Henry Ford Hospital between 2011 and 2013.